What Is the Best Pain Relief for Polymyalgia?

Low-dose glucocorticoids, specifically prednisone or prednisolone, remain the single most effective pain relief for polymyalgia rheumatica (PMR). International guidelines strongly recommend them over standard painkillers, and the response is often remarkably fast: many people feel dramatically better within a week of starting treatment. But the full picture is more complicated than “take steroids and feel better,” because the real challenge in PMR is not getting rid of the pain initially but managing the months or years of treatment that follow, including flares during dose reduction, steroid side effects, and the emerging question of whether newer biologic drugs might eventually change the standard of care.

Why Glucocorticoids Are First-Line

PMR causes pain and prolonged morning stiffness in the shoulders and hips, often severe enough to make getting dressed or climbing stairs difficult.¹ The underlying driver is inflammation, with the signaling molecule interleukin-6 (IL-6) playing a central role. Corticosteroids rapidly suppress IL-6 production, which is closely correlated with the severity of clinical symptoms.² That tight link between IL-6 and symptoms helps explain why steroids work so quickly and so completely in most people, and it also explains why drugs that don’t target this pathway fall short.

The 2015 European League Against Rheumatism / American College of Rheumatology (EULAR/ACR) guidelines strongly recommend glucocorticoids over nonsteroidal anti-inflammatory drugs (NSAIDs) for PMR.³ This is one of the clearest recommendations in rheumatology. Over-the-counter painkillers like ibuprofen or naproxen simply do not control PMR’s inflammatory process effectively. The guidelines note that NSAIDs or other analgesics might help with pain from other conditions a person has alongside PMR, but they are not treatment for PMR itself.

Starting Dose and Speed of Response

Most guidelines recommend starting prednisone at somewhere between 12.5 and 25 mg per day. An updated 2024 German, Austrian, and Swiss guideline recommends 15 to 25 mg of prednisone equivalents daily, initiated immediately after diagnosis.⁴ One study found that roughly four out of five patients responded to just 12.5 mg within a month, with the average time to remission being less than a week.⁵ That speed of relief is distinctive. If you start low-dose prednisone for suspected PMR and your pain barely changes after two or three weeks, your doctor will reasonably question whether PMR is actually the correct diagnosis.

The appropriate starting dose depends partly on body weight rather than how severe your symptoms feel at diagnosis.⁵ A heavier person may need a slightly higher starting dose to get the same relief. This is a practical detail worth discussing with your doctor if you are at the higher end of the weight range and not improving as fast as expected on a lower dose.

The Tapering Problem

Getting the pain under control is typically the easy part. The hard part is gradually reducing the steroid dose without triggering a relapse. Most people with PMR require treatment for one to three years, and some need it longer. Relapses during tapering are common and frustrating. Research favors a slow tapering approach from a low initial dose, somewhere in the 10 to 20 mg range, to reduce the risk of flare-ups.⁶

There is no single tapering schedule that works for everyone. Some rheumatologists describe dose reduction as more art than science, which is an honest admission that the disease behaves unpredictably. Close monitoring through regular blood tests for inflammation markers and honest conversations about symptoms is essential during this phase. If a flare happens, the typical approach is to bump the dose back up to the last level that controlled symptoms and then try tapering more slowly.

Why Not Just Use Ibuprofen or Paracetamol?

People naturally wonder whether they can avoid steroids entirely and manage PMR with common painkillers. The short answer is that standard painkillers do not adequately treat PMR. A study tracking adverse events found that patients treated with NSAIDs alone still experienced high rates of complications, and combining NSAIDs with corticosteroids pushed the adverse event rate even higher, to about 80%.⁷ So NSAIDs offer little benefit and add their own risks, particularly gastrointestinal and cardiovascular side effects in an older population already dealing with steroid-related concerns.

Paracetamol (acetaminophen) can take the edge off mild residual aches while you are on steroids, but it does nothing to address the underlying inflammation driving PMR. No guideline recommends analgesics alone as PMR treatment. If your pain is too mild to justify steroids, the question to ask is whether PMR is the right diagnosis in the first place.

Methotrexate as a Steroid-Sparing Add-On

For people who keep relapsing during steroid tapering, or who develop troublesome steroid side effects, methotrexate is the most commonly tried add-on medication. The evidence on whether it works is somewhat mixed but leans positive. A randomized trial found that patients taking methotrexate alongside prednisone were significantly more likely to be off steroids entirely by 76 weeks compared to those on prednisone alone.⁸ The methotrexate group also had fewer flare-ups and accumulated a lower total steroid dose.

A meta-analysis pooling results from randomized trials confirmed that methotrexate significantly reduced cumulative steroid exposure.⁹ However, an earlier trial using a low 7.5 mg weekly dose found no steroid-sparing effect at all.¹⁰ The dose and individual response appear to matter considerably. Methotrexate is not a pain reliever on its own for PMR; rather, it helps you get off steroids sooner and with fewer relapses, which indirectly reduces the total burden of treatment.

Biologic Drugs Targeting IL-6

Because IL-6 is so central to PMR symptoms, researchers have tested drugs that block this molecule directly. This is one of the more exciting areas in PMR treatment, though these medications are not yet standard first-line therapy for most patients.

Tocilizumab, an IL-6 receptor blocker already used for giant cell arteritis and rheumatoid arthritis, showed strong results in a phase 2/3 trial of newly diagnosed PMR patients. About 63% of people on tocilizumab achieved steroid-free remission by week 16, compared to roughly 12% on placebo. The tocilizumab group also took significantly longer to experience a first relapse and accumulated a lower total steroid dose.¹¹

Sarilumab, another IL-6 receptor blocker, was tested in patients with relapsing PMR who were already struggling during steroid tapering. By week 52, about 28% of sarilumab patients achieved sustained remission versus 10% on placebo. The median cumulative steroid dose in the sarilumab group was less than half that of the placebo group.¹² Sarilumab also improved quality-of-life measures, with patients reporting better physical function and mental health scores than the placebo group.¹³

Updated 2024 guidelines now recommend IL-6 receptor blockers as an add-on to glucocorticoids in patients with relapsing disease, with methotrexate or rituximab as alternatives. In select cases of newly diagnosed PMR with a high risk of steroid-related harm, biologics can also be considered upfront.⁴ These drugs are expensive and come with their own side effects, including a higher risk of infections, so they are not a casual substitute for prednisone. But for people trapped in a cycle of relapse and escalating steroid doses, they represent a genuine advance.

Managing Steroid Side Effects

Long-term glucocorticoid use is not benign. A study of PMR patients found that about two-thirds experienced at least one adverse event from steroid therapy alone. The risks of diabetes, spinal fractures, and hip fractures were two to five times higher in PMR patients compared to age- and sex-matched people from the same community.⁷ Higher cumulative prednisone doses, older age, and female sex all independently increased the risk of complications.

Bone protection is a major practical concern. Guidelines recommend that most people starting long-term steroids should receive some form of osteoporosis prevention, yet a study found that nearly a quarter of PMR patients received no calcium, vitamin D, or bisphosphonate treatment at all during their care.¹⁴ If you are starting steroids for PMR and your doctor has not discussed bone protection, raise it yourself. At a minimum, adequate calcium and vitamin D supplementation should be part of the conversation, with stronger medications like bisphosphonates added based on your fracture risk. One trial found that calcium and vitamin D alone preserved bone density reasonably well over two years of steroid use, with the addition of salmon calcitonin offering no further benefit.¹⁵

Beyond bone health, you should watch for blood sugar changes, weight gain, mood disturbances, skin thinning, and elevated blood pressure. These risks are dose-dependent and time-dependent, which is precisely why tapering to the lowest effective dose as quickly as safely possible is so important. People whose disease responds poorly to tapering accumulate both higher medical costs and more steroid-related complications over time.¹⁶

Exercise and Physical Therapy

Steroids handle the inflammation, but they do not restore the muscle strength, flexibility, and confidence that months of pain and stiffness erode. Updated guidelines now recommend that older or frailer patients be offered an individualized exercise program alongside drug treatment.⁴ A UK survey of physiotherapists treating PMR found that the vast majority prescribed individualized, graded exercises focusing on the upper limbs to improve movement, muscle strength, and the ability to carry out daily activities.¹⁷

Exercise also helps counteract some steroid side effects: it supports bone density, improves mood, and helps manage weight. The key is starting gently and building up. Many people with PMR are wary of physical activity because their pre-treatment experience was that movement hurt. Once steroids have brought the inflammation under control, gradually reintroducing activity is both safe and beneficial. Swimming, walking, and light resistance work are commonly recommended starting points.

Complementary Approaches

Many people with PMR try non-drug therapies alongside their medication. A cohort study found that about a third of participants used some form of complementary therapy, with exercise, dietary changes, and various hands-on therapies being the most popular choices. However, no individual non-pharmacological therapy was clearly associated with better long-term outcomes.¹⁸ That does not mean these approaches are worthless for quality of life or comfort, but it does mean there is no robust evidence that any supplement, diet, or alternative therapy can replace glucocorticoids or meaningfully shorten the treatment course.

If you want to try anti-inflammatory diets, acupuncture, or massage, there is little harm in doing so alongside standard treatment, as long as you do not reduce or stop your prescribed medication based on how you feel from these additions alone. PMR can temporarily improve and then flare unpredictably, so attributing improvement to a supplement when your steroids are doing the heavy lifting is a common trap.

The Giant Cell Arteritis Connection

PMR and giant cell arteritis (GCA) are closely related inflammatory conditions that frequently occur together.¹⁹ Studies suggest that roughly a quarter of newly diagnosed PMR patients have subclinical GCA detectable on imaging, even without classic GCA symptoms like headache or jaw pain.²⁰ This matters for pain management because GCA is a more serious condition that can threaten vision and requires higher steroid doses.

If you develop new headaches, scalp tenderness, jaw discomfort when chewing, or any visual changes while being treated for PMR, contact your doctor urgently. These symptoms raise the possibility of GCA, and early treatment can prevent irreversible complications. The pain-relief strategy shifts significantly when GCA enters the picture, typically requiring higher-dose steroids and often the addition of tocilizumab.

When Diagnosis Is Wrong

One reason pain relief might seem inadequate is that PMR is being treated when the true diagnosis is something else. There is no blood test specific to PMR, and the diagnosis depends on a combination of symptoms, physical examination, lab markers, and ruling out conditions that look similar.²¹ Rheumatoid arthritis, late-onset spondyloarthritis, and even certain cancers or infections can mimic PMR’s shoulder and hip pain pattern. Small-vessel vasculitis is another mimic, particularly in older adults.²²

The classic diagnostic clue that supports a PMR diagnosis is a rapid, dramatic response to low-dose prednisone. If you start steroids and your pain barely budges, or if it keeps coming back despite adequate doses, your doctor should reconsider whether the diagnosis is correct. Case reports describe patients who were treated for PMR for extended periods, sometimes undergoing unnecessary procedures, before the true diagnosis was identified.²³

The Emotional Weight of PMR Pain

PMR’s impact goes well beyond stiff shoulders. Social media analysis of patient conversations found that pain was the dominant concern affecting physical quality of life, and that it cascaded into difficulty walking, poor sleep, reduced ability to work, and emotional distress including depression and anxiety.²⁴ Patients also described anxiety related to the unpredictable nature of the disease and the stress of steroid tapering. Financial and social consequences were mentioned as well, with restricted movement and inability to work compounding the burden.

This emotional dimension is worth acknowledging because it affects how people experience and report their pain. A treatment plan that addresses only the inflammatory component while ignoring sleep disruption, deconditioning, mood changes (some of which steroids themselves cause), and the psychological toll of chronic illness will feel incomplete even if the blood work looks good. If your PMR pain is technically “controlled” by markers but you still feel terrible, bring that up with your care team. Quality-of-life measures in the sarilumab trial showed that effective treatment improved mental health scores alongside physical ones, suggesting that getting the inflammation properly controlled has real downstream effects on emotional well-being too.¹³

Monitoring During Treatment

Once you are on treatment, regular monitoring helps guide dose adjustments and catch complications early. Blood markers like ESR and CRP are commonly tracked, though both have limitations. Steroids suppress these markers directly, which can make them less reliable indicators of true disease activity while you are on treatment.²⁵ Research in the related condition GCA suggests that ESR may be somewhat better than CRP at identifying relapses, particularly at lower steroid doses later in the treatment course. In practice, your doctor will combine lab results with your symptom report, and the symptom report often matters more. A rising ESR alone without worsening stiffness or pain does not necessarily mean you are relapsing, and worsening symptoms with a normal ESR still warrant attention.

Visits also serve as opportunities to screen for steroid side effects: checking blood sugar, monitoring blood pressure, and periodically assessing bone density. During the first year after diagnosis, people with PMR tend to use considerably more healthcare services and lab tests than they did before, though this settles down in subsequent years.²⁶ That early intensity is appropriate and expected. PMR management is front-loaded: the first year requires the most adjustment, the most monitoring, and the most patience.